| Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia (NCT04234698) | Pfizer | 2021-03-22 |
| MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma (NCT04798586) | Pfizer | 2021-03-22 |
| Drug Use Investigation of COMIRNATY Intramuscular Injection (NCT04815031) | Pfizer | 2021-03-20 |
| Retrospective Real World Oxbryta® Data Collection and Analysis Study (NCT04930328) | Pfizer | 2021-03-20 |
| Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib (NCT04753658) | Pfizer | 2021-03-19 |
| PF-07284892 in Participants With Advanced Solid Tumors (NCT04800822) | Pfizer | 2021-03-17 |
| A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants (NCT04628793) | Pfizer | 2021-03-16 |
| PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older (NCT04613375) | Pfizer | 2021-03-12 |
| A Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions. (NCT04550936) | Pfizer | 2021-03-10 |
| Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population (NCT04801420) | Pfizer | 2021-03-08 |
| Korea Post Marketing Surveillance (PMS) Study of Vizimpro (NCT04721106) | Pfizer | 2021-03-07 |
| Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy (NCT04736576) | Pfizer | 2021-02-24 |
| STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS (NCT04756531) | Pfizer | 2021-02-11 |
| Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS (NCT04697381) | Pfizer | 2021-02-09 |
| Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole (NCT04735367) | Pfizer | 2021-02-03 |
| MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb (NCT04649359) | Pfizer | 2021-02-02 |
| Retrospective Analysis of Real World Use of Ceftazidime-avibactam in the Management of Gram Negative Infections (NCT04628572) | Pfizer | 2021-01-29 |
| A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity (NCT04707313) | Pfizer | 2021-01-29 |
| A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERS (NCT04126044) | Pfizer | 2021-01-22 |
| Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy. (NCT04721821) | Pfizer | 2021-01-22 |
| A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis (NCT04721808) | Pfizer | 2021-01-22 |
| Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries (NCT04669366) | Pfizer | 2021-01-20 |
| Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older (NCT04648241) | Pfizer | 2021-01-18 |
| A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma (NCT04657991) | Pfizer | 2021-01-15 |
| Randomized Study in Children and Adolescents With Migraine: Acute Treatment (NCT04649242) | Pfizer | 2021-01-15 |
| STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT (NCT04616027) | Pfizer | 2021-01-13 |
| A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement (NCT04543188) | Pfizer | 2021-01-08 |
| A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY (NCT04617275) | Pfizer | 2021-01-06 |
| Global Prevalence of ATTR-CM in Participants With HFpEF (NCT04424914) | Pfizer | 2020-12-30 |
| STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT (NCT04604496) | Pfizer | 2020-12-30 |
| Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria (NCT03580044) | Pfizer | 2020-12-25 |
| Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) (NCT04706793) | Pfizer | 2020-12-25 |
| Actigraphy Improvement With Voxelotor (ActIVe) Study (NCT04400487) | Pfizer | 2020-12-21 |
| A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors (NCT04672460) | Pfizer | 2020-12-21 |
| Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis (NCT04664153) | Pfizer | 2020-12-21 |
| Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants (NCT04655040) | Pfizer | 2020-12-18 |
| Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors (NCT04628780) | Pfizer | 2020-12-16 |
| Swedish Ibrance Registries Insights (SIRI) (NCT04654208) | Pfizer | 2020-12-15 |
| A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis (NCT04682639) | Pfizer | 2020-12-15 |
| Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers. (NCT04647110) | Pfizer | 2020-12-14 |
| Anticoagulation in Patients With Venous Thromboembolism and Cancer (NCT04618913) | Pfizer | 2020-12-14 |
| Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis (NCT04668066) | Pfizer | 2020-12-10 |
| A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants (NCT05036512) | Pfizer | 2020-12-09 |
| Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease (NCT03414788) | Pfizer | 2020-12-07 |
| A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel. (NCT04671615) | Pfizer | 2020-12-06 |
| Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age (NCT04642079) | Pfizer | 2020-12-04 |
| Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis (NCT04424303) | Pfizer | 2020-12-04 |
| A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia (NCT04638153) | Pfizer | 2020-12-02 |
| A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants (NCT04645966) | Pfizer | 2020-11-26 |
| Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants (NCT04427917) | Pfizer | 2020-11-24 |
| Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. (NCT04299048) | Pfizer | 2020-11-17 |
| Study of PF-07248144 in Advanced or Metastatic Solid Tumors (NCT04606446) | Pfizer | 2020-11-16 |
| Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease (NCT04218084) | Pfizer | 2020-11-11 |
| A Study To Asses Mass Balance And Absolute Bioavailability Of 14C PF-06826647 In Healthy Male Participants (NCT04591262) | Pfizer | 2020-11-10 |
| Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study) (NCT04585815) | Pfizer | 2020-11-10 |
| Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy (NCT04281485) | Pfizer | 2020-11-05 |
| STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY (NCT04616339) | Pfizer | 2020-11-04 |
| Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare (NCT04681482) | Pfizer | 2020-11-02 |
| Acute Myeloid Leukemia Real World Treatment Patterns (NCT04230564) | Pfizer | 2020-10-31 |
| First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting. (NCT04767594) | Pfizer | 2020-10-27 |
| Randomized Trial in Adult Participants With Acute Migraines (NCT04571060) | Pfizer | 2020-10-27 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus (NCT04552470) | Pfizer | 2020-10-26 |
| Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants (NCT04627532) | Pfizer | 2020-10-23 |
| Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine (NCT04574362) | Pfizer | 2020-10-22 |
| PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS (NCT04634565) | Pfizer | 2020-10-15 |
| Real World Study Of The Clinical Profile And Treatment Outcomes Of Advanced Therapies For Ulcerative Colitis In Portugal (NCT04156672) | Pfizer | 2020-10-06 |
| Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector (NCT05264493) | Pfizer | 2020-10-06 |
| Clinical Study to Evaluate Pharmacokinetics and Safety of PF-06700841 After Single and Multiple Oral Doses as Modified Release Formulations (NCT04580797) | Pfizer | 2020-10-02 |
| A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis (NCT04209556) | Pfizer | 2020-09-30 |
| Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer (NCT04362072) | Pfizer | 2020-09-29 |
| A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) (NCT04516291) | Pfizer | 2020-09-28 |
| Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules. (NCT04390776) | Pfizer | 2020-09-28 |
| Study of PF-07265807 in Participants With Metastatic Solid Tumors. (NCT04458259) | Pfizer | 2020-09-24 |
| Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors (NCT04557449) | Pfizer | 2020-09-23 |
| Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients (NCT04079920) | Pfizer | 2020-09-22 |
| Study To Evaluate The Pharmacokinetic, Safety And Tolerability Of Single Or Multiple Subcutaneous Doses of Recifercept (NCT04543344) | Pfizer | 2020-09-17 |
| A Study to Determine the Bioequivalence of Two Doses of Tafamidis (NCT04575116) | Pfizer | 2020-09-17 |
| Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed Condition (NCT04549480) | Pfizer | 2020-09-16 |
| PF-07104091 as a Single Agent and in Combination Therapy (NCT04553133) | Pfizer | 2020-09-16 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants (NCT04530838) | Pfizer | 2020-09-16 |
| Axitinib Therapy Management Study (NCT04555603) | Pfizer | 2020-09-15 |
| PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA (NCT04517864) | Pfizer | 2020-09-15 |
| Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden (NCT04338204) | Pfizer | 2020-09-14 |
| A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis (NCT04498403) | Pfizer | 2020-09-14 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants (NCT04546425) | Pfizer | 2020-09-09 |
| Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age (NCT04526574) | Pfizer | 2020-09-01 |
| Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel (NCT04507776) | Pfizer | 2020-09-01 |
| Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations (NCT04511533) | Pfizer | 2020-08-27 |
| Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids (NCT04267250) | Pfizer | 2020-08-24 |
| Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults (NCT04370054) | Pfizer | 2020-08-18 |
| Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis (NCT04399538) | Pfizer | 2020-08-10 |
| Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment (NCT04486625) | Pfizer | 2020-08-10 |
| Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated Triglycerides (NCT04459767) | Pfizer | 2020-08-06 |
| Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment (NCT04435769) | Pfizer | 2020-08-04 |
| Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma (NCT03878719) | Pfizer | 2020-08-03 |
| Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis (NCT04507763) | Pfizer | 2020-08-01 |
| TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE (NCT04413617) | Pfizer | 2020-07-29 |
| Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata (NCT04556734) | Pfizer | 2020-07-29 |
| Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis (NCT04360187) | Pfizer | 2020-07-27 |
| A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia (NCT04350606) | Pfizer | 2020-07-25 |